NOT KNOWN FACTUAL STATEMENTS ABOUT ABBV-744 PRECLINICAL STUDIES AND RESULTS

In Phase A, members will obtain various doses and schedules of oral ABBV-744 pill to recognize Risk-free dosing regimen. More individuals will likely be enrolled in the discovered monotherapy dosign routine. In Phase B, members will get oral ruxolitinib and ABBV-744 will probably be given as "increase-on" therapy. In Segment C, contributors will ob